Tariquidar is a potent third-generation inhibitor of P-glycoprotein (P-gp), a drug efflux pump that plays a significant role in the resistance of cancer cells to chemotherapy. It is a non-competitive antagonist that binds to P-gp and inhibits its function, thereby increasing the intracellular concentration of chemotherapeutic drugs.
